2C). As a result, the normalized fold expansions over a 100-fold input range was within fourfold of each other (Fig. 2D; (103 = 5–21 fold, 104 = 5–19 fold, 105 = 0.4–8 fold—potentially 6–8 fold excluding an outlier)). Therefore, unlike the responses to acute antigen, that to a chronic antigen seems to be largely precursor frequency independent. Furthermore, the extra burst of continued expansion seen in the acutely challenged lower precursor frequency groups between days 4 and 8 was also absent in the self-antigen stimulated T cells — contributing to a surprisingly synchronous

dynamics at all precursor frequencies tested. However, the most Dorsomorphin price striking feature of the 5C.C7 response to chronic antigen, especially at lower frequencies

is the absence of any obvious contraction after the initial expansion. At low frequencies (103 and 104 input), the expanded T cells reach a plateau phase that maintained the cell numbers reached at the peak (Fig. 2C and F). This was not a sampling error since closer time points between days 4 and 12 also did not reveal any transient peak or crash (data not shown). The 105 group does go through a short deletion phase, but quickly reaches a plateau number of ∼20,000 T cells, comparable to the lower frequency groups — suggesting that this density represents the number of postexpansion 5C.C7 T cells that can be supported over the long term in the presence Romidepsin molecular weight of chronic antigen stimulation. The

“crash phase” then, is likely to be a simple homeostatic correction of the overshoot of cell density in the higher frequency groups (105 shown here and 106 previously reported [5]) as they move toward this set point. This plateau is stable for as long as 135 days (Fig. 2F). In the case of the acute antigen (Fig. 2E), the cells do seem to crash below this set point, suggesting that chronic antigen recognition plays an important role in this maintenance phase. Although absolute numbers of T cells show variability between experiments (comparing Fig. 2A versus 2E and 2C versus 2F), the profile and even the plateau reached by 103 groups, especially in the chronic antigen model was surprisingly coherent over three experiments. A similar behavior was also observed in a second model Protirelin tracking male antigen (Dby) specific TCR-transgenic T cells (A1(M)) in male mice (Supporting Information Fig. 2B). The variation in absolute numbers in the acute challenge model (see Fig. 2A versus 2E) makes it difficult to conclude if the precursor frequency does have an impact on the number of T cells recovered in this context at very late time points (30+ days). However, in two additional experiments the number of T cells recovered very late after an acute challenge of high or low precursor infusions was not statistically significant (Supporting Information Fig. 2A). Finally, in the model of 5C.